Does Medicare Cover GLP-1 Weight Loss Medications in 2026?

If you are on Medicare and have been wondering whether Part D will cover GLP-1 medications like Wegovy or Zepbound for weight loss, the answer changed significantly in 2026. Starting July 1, 2026, a new federal pilot program — the Medicare GLP-1 Bridge — caps out-of-pocket costs at $50 per month for eligible Medicare Part D beneficiaries who meet specific clinical criteria. This article breaks down exactly what is covered, who qualifies, what the enrollment process looks like, and what to bring to your next doctor appointment.

What changed: the Medicare GLP-1 Bridge program

Historically, Medicare Part D did not cover anti-obesity medications for weight management. GLP-1 drugs like semaglutide and tirzepatide were only covered for Type 2 diabetes (under brand names like Ozempic and Mounjaro), not for weight loss. That meant seniors who wanted Wegovy or Zepbound for obesity had to pay full retail price — often $1,000 or more per month out of pocket.

The Medicare GLP-1 Bridge program changes that. Beginning July 1, 2026, Medicare Part D will cover select FDA-approved GLP-1 medications prescribed specifically for chronic weight management, with a monthly copay capped at $50 for beneficiaries who meet the clinical eligibility requirements.

Which GLP-1 medications does Medicare cover under the Bridge program?

The Bridge program covers specific brand-name medications that carry an FDA-approved indication for chronic weight management. Based on publicly reported program details, the covered medications include:

• Wegovy (semaglutide 2.4 mg injection) — the most widely prescribed GLP-1 for weight loss.
• Zepbound (tirzepatide injection) — specific formulations approved for chronic weight management.
• Foundayo (orforglipron) — a newer oral GLP-1 option that does not require injection.

Ozempic and Mounjaro are not included in the Bridge program because they are FDA-approved for Type 2 diabetes, not weight management. However, if you have Type 2 diabetes, those medications may already be covered under your existing Part D formulary — ask your prescriber.

Who qualifies for Medicare GLP-1 coverage?

The eligibility criteria for the Bridge program are based on clinical guidelines from the Centers for Medicare and Medicaid Services (CMS). To qualify, you generally must meet all of the following:

• You are currently enrolled in a Medicare Part D prescription drug plan.
• Your BMI is 35 or higher, OR your BMI is 27 or higher with at least one weight-related health condition such as pre-diabetes, cardiovascular disease, uncontrolled hypertension, or obstructive sleep apnea.
• Your prescribing physician submits a prior authorization through the program central processor (managed by Humana).
• The medication is prescribed specifically for chronic weight management — not off-label use.

Because BMI is such a central part of the eligibility decision, it helps to understand exactly what it is and how to calculate it yourself before your appointment.

How to calculate your BMI

BMI stands for Body Mass Index. It is a simple number calculated from your height and weight that doctors use to screen for weight categories. The formula looks complicated at first glance, but it only requires two measurements you already know: your weight in pounds and your height in inches.

The BMI formula

BMI = (weight in pounds x 703) ÷ (height in inches x height in inches)

That is: multiply your weight by 703, then divide the result by your height in inches squared.

Step-by-step example

Let us walk through a real example. Suppose you are 5 feet 6 inches tall and weigh 217 pounds.

• Step 1 — Convert your height to inches. 5 feet = 60 inches. Add the extra 6 inches: 60 + 6 = 66 inches total.
• Step 2 — Square your height in inches. 66 x 66 = 4,356.
• Step 3 — Multiply your weight by 703. 217 x 703 = 152,551.
• Step 4 — Divide the result from Step 3 by the result from Step 2. 152,551 ÷ 4,356 = 35.02.

In this example, the BMI is 35.0 — which meets the Bridge program threshold of 35 or higher for coverage without requiring an additional qualifying health condition.

A second example with a lower BMI

Now suppose you are 5 feet 4 inches tall and weigh 160 pounds.

• Step 1 — Convert height to inches. 5 feet = 60 inches. Add 4: 60 + 4 = 64 inches total.
• Step 2 — Square your height. 64 x 64 = 4,096.
• Step 3 — Multiply weight by 703. 160 x 703 = 112,480.
• Step 4 — Divide. 112,480 ÷ 4,096 = 27.46.

This BMI of 27.5 is below 35 but above 27 — so this person would qualify for the Bridge program if they also have at least one weight-related health condition such as pre-diabetes, high blood pressure, cardiovascular disease, or sleep apnea.

Quick BMI reference table

Below are approximate BMI values for several common height and weight combinations. Find the row closest to your height and look across to see where your weight falls:

• 5 ft 2 in (62 in): BMI 27 ≈ 148 lbs — BMI 30 ≈ 164 lbs — BMI 35 ≈ 191 lbs
• 5 ft 4 in (64 in): BMI 27 ≈ 157 lbs — BMI 30 ≈ 174 lbs — BMI 35 ≈ 204 lbs
• 5 ft 6 in (66 in): BMI 27 ≈ 167 lbs — BMI 30 ≈ 186 lbs — BMI 35 ≈ 217 lbs
• 5 ft 8 in (68 in): BMI 27 ≈ 177 lbs — BMI 30 ≈ 197 lbs — BMI 35 ≈ 230 lbs
• 5 ft 10 in (70 in): BMI 27 ≈ 188 lbs — BMI 30 ≈ 209 lbs — BMI 35 ≈ 243 lbs
• 6 ft 0 in (72 in): BMI 27 ≈ 199 lbs — BMI 30 ≈ 221 lbs — BMI 35 ≈ 258 lbs

Your doctor will calculate your official BMI at your appointment, but knowing your approximate number ahead of time helps you understand whether you are likely to qualify and which eligibility pathway applies to you.

How much will a GLP-1 cost on Medicare after July 2026?

Under the Bridge program, the maximum you will pay out of pocket is $50 per month for a covered GLP-1 medication. This copay cap applies regardless of which covered medication you are prescribed and regardless of your dose level.

For context, here is what these medications typically cost without coverage:

• Wegovy: approximately $1,300 to $1,400 per month retail.
• Zepbound: approximately $1,000 to $1,100 per month retail.
• Foundayo (oral): pricing not yet widely reported, but expected to be in a similar range.

The difference between $1,300 and $50 is why this program matters. For most Medicare beneficiaries, this is the first time GLP-1 weight loss medications have been financially accessible.

How to enroll: step by step

You do not enroll in the Bridge program yourself. Your doctor initiates the process. Here is what the enrollment path looks like:

• Step 1: Schedule an appointment with your primary care physician or an obesity medicine specialist. Tell them you are interested in GLP-1 medication for weight management and that you want to explore the Medicare Bridge program.
• Step 2: Your doctor evaluates whether you meet the clinical criteria (BMI thresholds and qualifying health conditions).
• Step 3: If you qualify, your doctor submits a prior authorization request through Humana, the central processor for the Bridge program. This includes your BMI, relevant diagnoses, and the specific medication being prescribed.
• Step 4: Once approved, your prescription is sent to a participating retail pharmacy (such as CVS, Walgreens, or a local independent pharmacy).
• Step 5: You pick up your medication and pay your $50 copay.

The prior authorization step is where most delays happen. Having your medical records, recent lab work, and a clear BMI measurement ready for your appointment will help your doctor complete the paperwork faster.

What to bring to your doctor appointment

If you are planning to ask your doctor about the Bridge program, here is a practical checklist of what to bring or prepare:

• Your Medicare Part D plan card and plan name.
• A current list of all medications you take, including dosages.
• Your most recent height and weight (your doctor will confirm, but knowing ahead of time helps).
• Any recent lab results — especially A1C, fasting glucose, blood pressure readings, or lipid panels.
• A written list of weight-related health conditions you have been diagnosed with (hypertension, pre-diabetes, sleep apnea, cardiovascular disease, PCOS, etc.).
• A note of any previous weight management programs you have tried (diet programs, exercise plans, bariatric surgery consultations) — many prior authorization forms ask about this.

What the Bridge program does not cover

The program has specific boundaries. Understanding what is not included helps set realistic expectations:

• Compounded medications — only FDA-approved brand-name products qualify.
• Medications prescribed off-label (for example, Ozempic used for weight loss instead of diabetes).
• Over-the-counter supplements, protein products, or nutritional support.
• Gym memberships, dietitian visits, or coaching programs (though some Medicare Advantage plans may offer these separately).
• Coverage beyond the pilot period — the Bridge program is structured as a time-limited pilot. Future extension depends on federal policy decisions.

Common questions seniors are asking

I have diabetes and obesity — does this affect my options?

Yes, and it may expand them. If you have Type 2 diabetes, your Part D plan may already cover Ozempic or Mounjaro under the diabetes formulary. The Bridge program adds coverage for medications prescribed specifically for weight management. Your doctor can help determine which medication and which coverage pathway makes the most sense for your situation.

Can my doctor prescribe this over telehealth?

In many cases, yes. The prior authorization process does not require an in-person visit in all circumstances. However, your doctor will need accurate height, weight, and potentially lab work to complete the paperwork. Check with your specific provider about whether a telehealth visit can work for the initial evaluation.

What if my prior authorization is denied?

Denials happen, and they can be appealed. Common reasons for denial include incomplete documentation, missing lab results, or a BMI calculation that falls just below the threshold. Your doctor can resubmit with additional documentation. If you receive a denial, ask your prescriber to walk you through the appeal process — it is a standard part of Medicare coverage.

Why this matters for long-term health

For millions of Medicare beneficiaries, the Bridge program represents the first realistic opportunity to access medications that clinical trials have shown can produce significant, sustained weight loss — typically 12 to 20 percent of body weight over 12 to 18 months, depending on the medication and individual response.

But the medication is only one piece. Clinical data consistently shows that people who combine GLP-1 medications with consistent daily habits — adequate protein intake, hydration, light strength training, and symptom awareness — achieve better outcomes and are more likely to maintain their results long-term.

That daily habit layer is exactly what CairnSpace was built for. The free meal logger, daily check-in, and symptom tracker are designed specifically for people on GLP-1 medications — whether you are just starting to research your options or you have already picked up your first prescription. Everything is private, there is no cost, and your data is never sold.

Related Articles

• The Medicare GLP-1 Bridge Program: What It Is, Who Qualifies, and How to Enroll
• What Does a GLP-1 Medication Actually Cost on Medicare After July 2026?
• How to Talk to Your Doctor About GLP-1 Medications on Medicare

Sources and further reading

Information in this article is drawn from publicly available sources, including:

• Centers for Medicare and Medicaid Services (CMS) — Medicare Part D coverage policies and program announcements.
• FDA prescribing information for Wegovy (semaglutide), Zepbound (tirzepatide), and related GLP-1 medications.
• Published outcomes from the STEP (semaglutide) and SURMOUNT (tirzepatide) clinical trial programs.
• National Institutes of Health — BMI calculation methodology and classification guidelines.
• Medicare.gov — official beneficiary resources for prescription drug coverage.

This article is general education only. Medicare policy can change, and individual eligibility varies. Always verify your coverage and eligibility directly with Medicare (1-800-MEDICARE) or your Part D plan administrator.